| Product NDC: | 42549-646 |
| Proprietary Name: | CYMBALTA |
| Non Proprietary Name: | DULOXETINE HYDROCHLORIDE |
| Active Ingredient(s): | 30 mg/1 & nbsp; DULOXETINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42549-646 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021427 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20040824 |
| Package NDC: | 42549-646-30 |
| Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42549-646-30) |
| NDC Code | 42549-646-30 |
| Proprietary Name | CYMBALTA |
| Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42549-646-30) |
| Product NDC | 42549-646 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DULOXETINE HYDROCHLORIDE |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20040824 |
| Marketing Category Name | NDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | DULOXETINE HYDROCHLORIDE |
| Strength Number | 30 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |